The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

47 articles for S Rivara


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Metadynamics for Perspective Drug Design: Computationally Driven Synthesis of New Protein-Protein Interaction Inhibitors Targeting the EphA2 Receptor.EBI
University of Parma
Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents.EBI
Alma Mater Studiorum-University of Bologna
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors.EBI
University of Parma
¿(5)-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin system.EBI
University of Parma
New coumarin-based fluorescent melatonin ligands. Design, synthesis and pharmacological characterization.EBI
IQM-CSIC
Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines.EBI
University of Urbino
Novel N-Acetyl Bioisosteres of Melatonin: Melatonergic Receptor Pharmacology, Physicochemical Studies, and Phenotypic Assessment of Their Neurogenic Potential.EBI
IQM-CSIC
ST7612AA1, a thioacetate-¿(¿-lactam carboxamide) derivative selected from a novel generation of oral HDAC inhibitors.EBI
R&D Sigma-Tau Industrie Farmaceutiche Riunite
Towards the development of 5-HT7 ligands combining serotonin-like and arylpiperazine moieties.EBI
University of Urbino
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.EBI
The German University In Cairo
Amino acid conjugates of lithocholic acid as antagonists of the EphA2 receptor.EBI
University of Parma
Synthesis of (E)-8-(3-chlorostyryl)caffeine analogues leading to 9-deazaxanthine derivatives as dual A(2A) antagonists/MAO-B inhibitors.EBI
University of Parma
Dibasic biphenyl H3 receptor antagonists: Steric tolerance for a lipophilic side chain.EBI
University of Parma
Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: steric effects of N-alkyl chain on rat plasma and liver stability.EBI
University of Parma
Bivalent ligand approach on N-{2-[(3-methoxyphenyl)methylamino]ethyl}acetamide: synthesis, binding affinity and intrinsic activity for MT(1) and MT(2) melatonin receptors.EBI
University of Urbino
Synthesis and structure-activity relationships of N-(2-oxo-3-oxetanyl)amides as N-acylethanolamine-hydrolyzing acid amidase inhibitors.EBI
University of California
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity.EBI
University of Parma
N-(2-oxo-3-oxetanyl)carbamic acid esters as N-acylethanolamine acid amidase inhibitors: synthesis and structure-activity and structure-property relationships.EBI
University of Urbino
Irreversible inhibition of epidermal growth factor receptor activity by 3-aminopropanamides.EBI
University of Parma
Novel irreversible epidermal growth factor receptor inhibitors by chemical modulation of the cysteine-trap portion.EBI
University of Parma
Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice.EBI
University of California
Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl alkylcarbamates.EBI
Università
Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell line.EBI
Universita di Parma
2-Arylmelatonin analogues: Probing the 2-phenyl binding pocket of melatonin MTEBI
University of Urbino Carlo Bo
Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.EBI
Università
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma.EBI
University of Parma
A sulfonyl fluoride derivative inhibits EGFREBI
University of Parma
Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors.EBI
Università
Balancing reactivity and antitumor activity: heteroarylthioacetamide derivatives as potent and time-dependent inhibitors of EGFR.EBI
University of Parma
Benzisothiazolinone Derivatives as Potent Allosteric Monoacylglycerol Lipase Inhibitors That Functionally Mimic Sulfenylation of Regulatory Cysteines.EBI
University of Parma
Novel Benzazole Derivatives Endowed with Potent Antiheparanase Activity.EBI
"Sapienza" Universit£
Long-lasting inhibition of EGFR autophosphorylation in A549 tumor cells by intracellular accumulation of non-covalent inhibitors.EBI
University of Parma
N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands.EBI
University of Parma
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid biphenyl scaffold.EBI
University of Parma
Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models.EBI
University of Parma
Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.EBI
University of Milan
Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation.EBI
University of Parma
2-N-acylaminoalkylindoles: design and quantitative structure-activity relationship studies leading to MT2-selective melatonin antagonists.EBI
University of Urbino
Melatonin receptor ligands: synthesis of new melatonin derivatives and comprehensive comparative molecular field analysis (CoMFA) study.EBI
University of Milan
Conformationally restrained melatonin analogues: synthesis, binding affinity for the melatonin receptor, evaluation of the biological activity, and molecular modeling study.EBI
University of Urbino
Novel Symmetrical Benzazolyl Derivatives Endowed with Potent Anti-Heparanase Activity.EBI
"Sapienza" Universit£
Identification of Bivalent Ligands with Melatonin Receptor Agonist and Fatty Acid Amide Hydrolase (FAAH) Inhibitory Activity That Exhibit Ocular Hypotensive Effect in the Rabbit.EBI
University of Urbino
Tetrahydroquinoline Ring as a Versatile Bioisostere of Tetralin for Melatonin Receptor Ligands.EBI
University of Parma
Atropisomerism and Conformational Equilibria: Impact on PI3Kδ Inhibition of 2-((6-Amino-9H-purin-9-yl)methyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one (IC87114) and Its Conformationally Restricted Analogs.EBI
University of Parma
Structural basis for binding and selectivity of antimalarial and anticancer ethylenediamine inhibitors to protein farnesyltransferase.BDB
Duke University Medical Center
Dual aromatase-steroid sulfatase inhibitors.BDB
University of Bath